Bioinspired super-hydrophilic zwitterionic polymer armor combats thrombosis and infection of vascular catheters
Source abstract
Abstract
Thrombosis and infection are two major complications associated with central venous catheters (CVCs), which significantly contribute to morbidity and mortality. Antifouling coating strategies currently represent an efficient approach for addressing such complications. However, existing antifouling coatings have limitations in terms of both duration and effectiveness. Herein, we propose a durable zwitterionic polymer armor for catheters. This armor is realized by pre-coating with a robust phenol-polyamine film inspired by insect sclerotization, followed by grafting of poly-2-methacryloyloxyethyl phosphorylcholine (pMPC) via in-situ radical polymerization. The resulting pMPC coating armor exhibits super-hydrophilicity, thereby forming a highly hydrated shell that effectively prevents bacterial adhesion and inhibits the adsorption and activation of fibrinogen and platelets in vitro. In practical applications, the armored catheters significantly reduced inflammation and prevented biofilm formation in a rat subcutaneous infection model, as well as inhibited thrombus formation in a rabbit jugular vein model. Overall, our robust zwitterionic polymer coating presents a promising solution for reducing infections and thrombosis associated with vascular catheters.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Central Venous Catheters and Hemodialysis · Vascular Procedures and Complications · Polymer Surface Interaction Studies
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (43)
Show source-provided references
1. Preventing complications of central venous catheterization10.1056/NEJMra011883 ↗
2. Central venous catheters10.1136/bmj.f6570 ↗
3. Dialysis central venous catheter types and performance10.5301/jva.5000262 ↗
4. Complications of central venous catheterization10.1016/j.jamcollsurg.2007.01.039 ↗
5. Mou · 2022 · 1
6. Central venous catheter mechanical irritation of the right atrial free wall:A cause for thrombus formation10.1159/000006905 ↗
7. Biofilm Formation on central venous catheters: a pilot study10.1016/j.jss.2022.06.072 ↗
8. Central venous catheters and biofilms: where do we stand in 2017?10.1111/apm.12665 ↗
9. Interventions other than anticoagulants and systemic antibiotics for prevention of central venous catheter‐related infections in children with cancer
10. Prophylactic antibiotics for preventing gram‐positive infections associated with long‐term central venous catheters in adults and children receiving treatment for cancer
11. Heparin-induced thrombocytopenia
12. Pitiriga · 2020 · vol. 9 · 1
13. Enhancing macrophages to combat intracellular bacteria10.59717/j.xinn-life.2023.100027 ↗
14. Immunomodulatory biomaterials against bacterial infections: progress, challenges, and future perspectives
15. Vascular catheters with a nonleaching poly-sulfobetaine surface modification reduce thrombus formation and microbial attachment10.1126/scitranslmed.3004120 ↗
16. A new in vitro blood flow model for the realistic evaluation of antimicrobial surfaces10.1002/adhm.202301300 ↗
17. Induction of platelet thrombi by bacteria and antibodies10.1182/blood-2002-01-0069 ↗
18. A scope at antifouling strategies to prevent catheter-associated infections10.1016/j.cis.2020.102230 ↗
19. Glycocalyx-inspired dynamic antifouling surfaces for temporary intravascular devices
20. Anti-fouling strategies for central venous catheters, cardiovasc diagn
21. Romantic surfaces: a systematic overview of stable, biospecific, and antifouling zwitterionic surfaces10.1021/acs.langmuir.8b03360 ↗
22. Anti-fouling coatings for blood-contacting devices10.1016/j.smaim.2023.10.001 ↗
23. Zwitterionic materials for antifouling membrane surface construction10.1016/j.actbio.2016.03.038 ↗
24. Molecular level studies on interfacial hydration of zwitterionic and other antifouling polymers in situ10.1016/j.actbio.2016.02.030 ↗
25. Superhydrophilicity and strong salt-affinity: zwitterionic polymer grafted surfaces with significant potentials particularly in biological systems10.1016/j.cis.2020.102141 ↗
26. Formation of antifouling functional coating from deposition of a zwitterionic-Co-nonionic polymer via “grafting to” approach10.1016/j.jscs.2019.05.011 ↗
27. An introduction to zwitterionic polymer behavior and applications in solution and at surfaces10.1039/C8CS00508G ↗
28. Surface zwitterionization of titanium for a general bio-inert control of plasma proteins, blood cells, tissue cells, and bacteria10.1021/la500917s ↗
29. Ultraviolet-visible (Uv-Vis) spectroscopy10.1007/978-981-15-1547-7_3 ↗
30. Non-biofouling materials prepared by atom transfer radical polymerization grafting of 2-methacryloloxyethyl phosphorylcholine: separate effects of graft density and chain length on protein repulsion10.1016/j.biomaterials.2005.07.006 ↗
31. Control of nanobiointerfaces generated from well-defined biomimetic polymer brushes for protein and cell manipulations10.1021/bm049613k ↗
32. Macroscale superlubricity achieved between zwitterionic copolymer hydrogel and sapphire in water10.1016/j.matdes.2019.108441 ↗
33. Evaluating and managing open skin wounds: colonization versus infection
34. Anti-inflammatory, antibacterial, and antioxidative bioactive glass-based nanofibrous dressing enables scarless wound healing10.1016/j.smaim.2023.01.001 ↗
35. Antibacterial activities of docosahexaenoic acid (dha) and eicosapentaenoic acid (epa) against planktonic and biofilm growing Streptococcus mutans10.1016/j.micpath.2017.03.040 ↗
36. Fibrinogen and fibrin in hemostasis and thrombosis10.1161/ATVBAHA.117.308564 ↗
37. Advances in the development of hemostatic biomaterials for medical application
38. Human fibrinogen adsorption on positively charged latex particles10.1021/la5025668 ↗
39. The pleiotropic role of the fibrinogen γ′ chain in hemostasis10.1182/blood-2009-05-217968 ↗
40. Interplay between platelets and coagulation10.1016/j.blre.2020.100733 ↗
41. Harnessing the power of inflammation in immunoprevention and immunotherapy10.59717/j.xinn-life.2023.100025 ↗
42. The blood compatibility challenge. Part 1: blood-contacting medical devices: the scope of the problem10.1016/j.actbio.2019.06.021 ↗
43. Protein adsorption in three dimensions10.1016/j.biomaterials.2011.10.059 ↗